FDA approves new treatment for hepatitis C
August 3, 2017 – The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.